GT
GEN

Glenmede Trust’s Genesis Healthcare, Inc. GEN Stock Holding History

Glenmede Trust’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-67
Closed – – 2764
2016
Q1 		$0 Hold
67
– – ﹤0.01% 2760
2015
Q4 		$0 Hold
67
– – ﹤0.01% 2818
2015
Q3 		$0 Buy
+67
New +$454 ﹤0.01% 2875

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Glenmede Trust's GEN Position: Q2 2016 in Review

Glenmede Trust sold out of Genesis Healthcare, Inc. (GEN) in Q2 2016, closing a stake of 67 shares.

Glenmede Trust first reported a position in GEN in Q3 2015 and held it in 3 quarters. The position peaked at $0 in Q1 2016. 61 funds tracked by Wall St. Rank hold GEN as of Q2 2016.

  • Glenmede Trust reported no remaining Genesis Healthcare, Inc. position as of Q2 2016 after selling out during the quarter.
  • Glenmede Trust sold 67 Genesis Healthcare, Inc. shares in Q2 2016.
  • Glenmede Trust first reported a position in Genesis Healthcare, Inc. in Q3 2015 and held it in 3 quarters.
  • Glenmede Trust's Genesis Healthcare, Inc. position peaked at $0 in Q1 2016.
  • 61 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2016.

Based on Glenmede Trust's 13F filing for Q2 2016, filed 5 Aug 2016.